Eczematized psoriasis – a frequent but often neglected variant of plaque psoriasis
Abstract: Psoriasis is a common chronic inflammatory skin disease that causes systemic inflammation and severely impacts the patient's quality of life. Several highly effective therapeutics for psoriasis have been approved in recent years. However, in real life, a high proportion of patients either do not experience the clinical improvement observed in clinical trials or develop a secondary loss of efficacy. This may be a result of unrecognized endotypes of psoriasis that need to be characterized in greater depth to enable selection of an appropriate therapy. Eczematized psoriasis, which occurs in approximately 5–10% of patients with psoriasis, is an often-neglected variant of psoriasis. The term “eczematized psoriasis” refers to patients developing psoriasis with similarities to eczema. These patients typically present with severe itching, and skin biopsies often reveal eosinophil granulocytes, serum crusts, or spongiosis, which are frequently observed in eczema. From an immunological perspective, additional signaling pathways that are responsible for eczema reactions might be activated in eczematized psoriasis compared to classical plaque psoriasis. This review summarizes the key clinical, histological, and immunological features of eczematized psoriasis, proposes diagnostic criteria, and evaluates the therapeutic options for eczematized psoriasis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Journal der Deutschen Dermatologischen Gesellschaft. - 21, 5 (2023) , 445-453, ISSN: 1610-0387
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2023
- Urheber
-
Lauffer, Felix
Eyerich, Kilian
- DOI
-
10.1111/ddg.14991
- URN
-
urn:nbn:de:bsz:25-freidok-2354601
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:46 MEZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lauffer, Felix
- Eyerich, Kilian
- Universität
Entstanden
- 2023
Ähnliche Objekte (12)
Ekzematisierte Psoriasis – eine häufige, aber oft vernachlässigte Variante der Plaque‐Psoriasis
Iatrogenic switch from psoriasis to eczema: what does it mean and is it predictable?
Psoriasis oder Ekzem? Einjährige Ergebnisse aus dem DGUV‐Forschungsprojekt FB323 mit Einsatz des Molekularen Klassifikators bei Berufsdermatosen
Psoriasis or eczema? One‐year results from the DGUV research project FB323 with application of the Molecular Classifier in occupational dermatoses
Ustekinumab : Behandlung der Plaque-Psoriasis und aktiven Psoriasis-Arthritis
Orale Psoriasis-Therapie mit Deucravacitinib : mittelschwere bis schwere Plaque-Psoriasis
Association of disease duration and PASI response rates at week 12 in patients with moderate-to-severe plaque psoriasis receiving biologics in the real-world psoriasis study of health outcomes (PSoHO)
Ustekinumab : bei mittelschwerer bis schwerer Plaque-Psoriasis : bei aktiver Psoriasis-Arthritis
Acute generalized pustular psoriasis successfully treated with the IL‐23p19 antibody risankizumab
Erfolgreiche Therapie einer akuten generalisierten pustulösen Psoriasis mit dem IL‐23p19‐Antikörper Risankizumab
Autosomal dominant inheritance with sex‐limited manifestation: An unusual mode of transmission in humans and animals
Bimekizumab bei mittelschwerer bis schwerer Plaque-Psoriasis
Ekzematisierte Psoriasis – eine häufige, aber oft vernachlässigte Variante der Plaque‐Psoriasis
Iatrogenic switch from psoriasis to eczema: what does it mean and is it predictable?
Psoriasis oder Ekzem? Einjährige Ergebnisse aus dem DGUV‐Forschungsprojekt FB323 mit Einsatz des Molekularen Klassifikators bei Berufsdermatosen
Psoriasis or eczema? One‐year results from the DGUV research project FB323 with application of the Molecular Classifier in occupational dermatoses
Ustekinumab : Behandlung der Plaque-Psoriasis und aktiven Psoriasis-Arthritis
Orale Psoriasis-Therapie mit Deucravacitinib : mittelschwere bis schwere Plaque-Psoriasis
Association of disease duration and PASI response rates at week 12 in patients with moderate-to-severe plaque psoriasis receiving biologics in the real-world psoriasis study of health outcomes (PSoHO)
Ustekinumab : bei mittelschwerer bis schwerer Plaque-Psoriasis : bei aktiver Psoriasis-Arthritis
Acute generalized pustular psoriasis successfully treated with the IL‐23p19 antibody risankizumab
Erfolgreiche Therapie einer akuten generalisierten pustulösen Psoriasis mit dem IL‐23p19‐Antikörper Risankizumab
Autosomal dominant inheritance with sex‐limited manifestation: An unusual mode of transmission in humans and animals
Bimekizumab bei mittelschwerer bis schwerer Plaque-Psoriasis
Ekzematisierte Psoriasis – eine häufige, aber oft vernachlässigte Variante der Plaque‐Psoriasis
Iatrogenic switch from psoriasis to eczema: what does it mean and is it predictable?
Psoriasis oder Ekzem? Einjährige Ergebnisse aus dem DGUV‐Forschungsprojekt FB323 mit Einsatz des Molekularen Klassifikators bei Berufsdermatosen
Psoriasis or eczema? One‐year results from the DGUV research project FB323 with application of the Molecular Classifier in occupational dermatoses
Ustekinumab : Behandlung der Plaque-Psoriasis und aktiven Psoriasis-Arthritis
Orale Psoriasis-Therapie mit Deucravacitinib : mittelschwere bis schwere Plaque-Psoriasis
Association of disease duration and PASI response rates at week 12 in patients with moderate-to-severe plaque psoriasis receiving biologics in the real-world psoriasis study of health outcomes (PSoHO)
Ustekinumab : bei mittelschwerer bis schwerer Plaque-Psoriasis : bei aktiver Psoriasis-Arthritis
Acute generalized pustular psoriasis successfully treated with the IL‐23p19 antibody risankizumab
Erfolgreiche Therapie einer akuten generalisierten pustulösen Psoriasis mit dem IL‐23p19‐Antikörper Risankizumab
Autosomal dominant inheritance with sex‐limited manifestation: An unusual mode of transmission in humans and animals